Legal Opinion
Cardiorentis Ag v. Iqvia Ltd.
North Carolina Business Court
Decided December 31, 2018No. 18-CVS-2313Published
1Opinion of the Court
Cardiorentis AG v. IQVIA Ltd., 2018 NCBC 137. STATE OF NORTH CAROLINA IN THE GENERAL COURT OF JUSTICE SUPERIOR COURT DIVISION DURHAM COUNTY 18 CVS 2313 CARDIORENTIS AG, Plaintiff, v. ORDER AND OPINION ON DEFENDANTS’ IQVIA LTD. and IQVIA RDS, INC., PRE-ANSWER MOTIONS Defendants. 1. Plaintiff Cardiorentis AG is a Swiss biopharmaceutical company. Its flagship drug, Ularitide, is a treatment for heart failure. In 2012, Cardiorentis enlisted IQVIA Ltd. (“IQVIA UK”), an English contract research organization, to perform a worldwide clinical trial of Ularitide with a view toward obtaining the…
2Cases cited34 opinions
- Gulf Oil Corp. v. GilbertSupreme Court of the United States · 1947
- Piper Aircraft Co. v. ReynoSupreme Court of the United States · 1982
- Sinochem International Co. v. Malaysia International Shipping Corp.Supreme Court of the United States · 2007
- Haynsworth v. the CorporationCourt of Appeals for the Fifth Circuit · 1997
- Peregrine Myanmar Ltd. And Peregrine Capital Myanmar Ltd. v. Miriam Marshall SegalCourt of Appeals for the Second Circuit · 1996
29 more not listed; retrieve them via the Exa API.